treatment of ataxia in patients with acute peripheral vertigo.
Phase 3
- Conditions
- Acute peripheral vertigo.Benign paroxysmal vertigo
- Registration Number
- IRCT2015120722777N2
- Lead Sponsor
- Vice chancellor for research,Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
aged between 18-60 years old; acute peripheral vertigo and ataxia.
exclusion criteria: history of syncope or cardiac event; considerations of a central origin for vertigo; focal neurological deficits; known pregnancy; evidence of drug-induced vertigo or orthostatic hypotension; known dystonic or adverse reaction to diazepam and promethazine or other similar agents; report of taking medication within 24 hours of ED presentation that might affect the results (e.g., antihistamines, antipsychotics, opioid analgesics or sedatives).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ataxia. Timepoint: 60 and 120 minutes after intervention. Method of measurement: Romberg Test and tandem gait test.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: 60 and 120 minutes after intervention. Method of measurement: Sphygmomanometer.;Heart Rate. Timepoint: 60 and 120 minutes after intervention. Method of measurement: Pulse oximetry.